1. Market Research
  2. > Healthcare Market Trends
  3. > Review of the Healthcare System and Medical Device Market in Sweden – report

This TforG Healthcare Market review report for Sweden includes numerical and written analysis on the socioeconomic and macroeconomic context and outlook, the healthcare system, and the latest healthcare reforms. Moreover, an extensive chapter is dedicated to the markets for capital equipment, medical devices, disposables and pharmaceuticals.

The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.

Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).

Economic Outlook:
- GDP growth rates continue to grow steadily in 2015 to 2.3 percent, recovering stably from a slightly negative growth rate dip in 2012.
-Unemployment rate has remained around 7.8 percent to 8.1 percent for the past three years and is forecasted to remain at this rate in the coming two years.
-The inflation rate was -0.3 percent in 2014 due to interest rates having been raised, and has returned to positive rates in 2014 and is expected to continue rising in the coming years.
-Sweden’s main exports are refined petroleum, vehicle parts, and cars. Their main industries include iron and steel, wood and paper products, processed foods, motorized vehicles and precision equipment, such as bearings, telephone and radio components, pharmaceuticals and armaments.
-Sweden’s public debt in 2014 was 36.5 percent, which is far below the European average of public debt around 64 percent. Credit rating agencies such as Fitch, Moody’s and Standard & Poor’s give Sweden a rating of AAA.

The Healthcare System:
- In 2014, health expenditure as a percentage of GDP was 9.64 percent.
- 81.71 percent is provided for by public health expenditure and 19.9 percent is privately sourced. This proportion of public spending is generously above the OECD average of 72 percent.
-Only 4 percent of the Swedish population has voluntary health insurance (VHI). The vast majority of the population is covered by the national insurance provider.
-Sweden’s health provision responsibilities (organization, provision and procurement) are shared between local municipality and county council governments.
-Private entities are allowed to run primary, secondary and tertiary care facilities and can be reimbursed publically.
- Sweden uses a mixture of co-payments; user charges, subsidies, grants and the DRG system to finance its healthcare system.

Reforms center around the following:
-New pricing model for pharmaceuticals; reducing and controlling the prices of pharmaceuticals and patent-expired medicine
-National Cancer Strategy; improving organization of cancer care, prevention and detection and building more Regional Cancer Centers
-Dissemination and management of healthcare relevant information; through e-health care infrastructures for stakeholders as well as for procurement processes, and through public information campaigns
-Patient Act; granting patient right to seek second medical opinion and be reimbursed for it

The Markets:
- In 2013, the Swedish medical equipment market (including medical devices and capital equipment) was estimated around 2.5 bln Euros.
- Sweden represents less than 1 percent of the global market for medical devices, yet it earns 4 percent of the same global market revenues.
- The Swedish government has prioritized certain areas for development including: care services for the elderly, innovation in procurement and processes, cancer care and finding a competitive balance in the privatization of public services.
- Sweden has an aging population and epidemiological profile attractive for manufacturers and providers of non-communicable disease medication, pharmaceuticals to treat chronic conditions and monitoring equipment.
-Sweden also seeks innovative solutions, efficiency, and cost-benefit analysis for their processes and healthcare provisions.

Reasons to buy:
– Accurate analysis of trends, opportunities and challenges of the economy and healthcare industry
– Relevant healthcare reforms
– Written and numerical analysis on important healthcare indicators (eg.: acute care data, critical care data, anesthesia data, emergency data, healthcare professionals)
– Regularly updates, at least once year
– Every update published by TforG within 6 months after your purchase will be made available to you
– Global coverage, available for + 40 countries
– Unique insight into the socio-economic dynamics, and analysis of their effect on healthcare systems

Table Of Contents

Review of the Healthcare System and Medical Device Market in Sweden - report
1.0 Executive Summary
2.0 Socioeconomic Outlook
2.1 Socioeconomic Context
2.2 Macroeconomics
2.3 Table 1.1 - Macroeconomics
2.4 Economic Outlook
3.0 The Swedish Healthcare System
3.1 Introduction
3.2 Healthcare Status
3.3 Healthcare Expenditures
3.4 Table 2.1 - Healthcare
3.5 The Organization
3.6 Federal Level
3.7 Regional Level
3.8 Local Level
3.9 Diagram 2.1 - Healthcare Organization
3.10 Primary Care
3.11 Secondary Care
3.12 Table 2.2 - Secondary Care
3.13 Tertiary Care
3.14 Healthcare Insurance
3.15 Healthcare Financing
3.16 Financial Flows
3.17 Diagram 2.2 - Financial Flow
3.18 Private versus Public
4.0 Healthcare Reforms
4.1 Current Challenges
4.2 Recent Reforms
4.3 Hospital Operations and Priorities
5.0 The Markets
5.1 Market Profile
5.2 Purchase Processes and Decision-Making
5.3 Pharmaceuticals
5.4 Capital Equipment
5.5 Medical Devices
5.6 Medical Disposables
5.7 Opportunities and Market Drivers
6.0 Country Overview
6.1 Demographics, Macroeconomics and Healthcare
7.0 National Care Provision Data
7.1 Acute Care Data
7.2 Critical Care
7.3 Anesthesia
7.4 Emergency
7.5 Hospital Services Data
7.6 Healthcare Professionals
8.0 The TforG Methodology
8.1 Primary Research
8.2 Secondary Research
8.3 Our Experience

Companies Mentioned
Gambro, Baxter, Getinge, Elekta, Mölnlycke Healthcare, Nobel Biocare, Permobil, Human Care, Atos Medical, Sectra, Etac, Nolato Cerbo, Benjamin, D Olsson Consulting, Deyark Service International Limited, and OneMed.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...

Healthcare Supply Chain Management Market by Component, Purchasing, Hardware, Delivery Mode and End User - Global Forecast to 2021

Healthcare Supply Chain Management Market by Component, Purchasing, Hardware, Delivery Mode and End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The healthcare supply chain management market is projected to reach USD 2.22 billion by 2021 from USD 1.45 billion in 2016, growing at a CAGR of 8.9% during the forecast period. Factors such as the Unique ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.